Study finds higher risk of rare blood cancer after chemo - NCI

An NIH study finds patients treated with chemotherapy for most solid tumors had an increased risk of tMDS/AML, a rare but often fatal type of leukemia.

Mitigating acute chemotherapy-associated adverse events in

Types of Leukemia: Common, Rare & More

What Is Leukemia? Roswell Park Comprehensive Cancer Center

Risk and adverse clinical outcomes of thrombocytopenia among

A Promising Cancer Treatment Made Patients Worse, Not Better - The

Blood Cancers: Types, Diagnosis, Prognosis

Advances in Leukemia Research - NCI

Study finds higher risk of rare blood cancer after chemo - NCI

Managing Side Effects of Leukemia Treatment in Children

Frontiers Cardiogenic shock among cancer patients

Pre-Treatment Chemotherapy Is a Breakthrough Cervical Cancer Care

Blood Cancer Treatment Breakthroughs & Research Advancements

T cell lymphoma and secondary primary malignancy risk after

Cancers, Free Full-Text

oncology – NIH Director's Blog